Principal Investigator: Dr. Sasha Bernatsky
Affiliation: Research Institute of the McGill University Health Centre
Start Year: 2018
In Canada , there are key knowledge gaps regarding the safety and effectiveness of drugs used in the real-world. Comparative effectiveness research is the direct comparison of existing therapies, in order to understand which treatment works best, for which patients, and under what circumstances. Health professionals, regulatory bodies, and other stakeholders need information on the safety and effectiveness of drugs used in the real world. Our ‘CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research’ (CAN-AIM) team’s objective is to fill in these knowledge gaps by answering specific queries from Health Canada and other regulatory parties, and by providing the best methods to answer future drug queries. In order to facilitate this, we will work with provincial directors of the groups contributing to the Canadian Partnership for Tomorrow’s Health as the data collected by CanPath represents an important resource for comparative effectiveness research. All data obtained from CanPath will be kept confidential and will not be shared with other researchers not approved by this application.